PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis
2007
New mTOR Interactors PRAS40 and PRR5L Regulate Apoptosis
publication
Evidence: moderate
Author Information
Author(s): Thedieck Kathrin, Polak Pazit, Kim Man Lyang, Molle Klaus D., Cohen Adiel, Jenö Paul, Arrieumerlou Cécile, Hall Michael N.
Primary Institution: Biozentrum, University of Basel, Basel, Switzerland
Hypothesis
PRAS40 and PRR5L are novel mTOR binding proteins that regulate apoptosis.
Conclusion
PRAS40 and PRR5L are identified as new mTOR interactors that play significant roles in regulating apoptosis.
Supporting Evidence
- PRAS40 binds specifically to mTORC1 and inhibits its activity.
- PRR5L binds specifically to mTORC2 and is not required for mTORC2 integrity.
- Knock down of PRAS40 protects cells from apoptosis induced by TNFα and cycloheximide.
- PRR5L knock down also reduces apoptosis in mTORC2 deficient cells.
Takeaway
Scientists found two new proteins that help control cell growth and death, which could be important for understanding cancer.
Methodology
The study used a two-dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) approach to identify mTOR binding proteins.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website